CV (CapsoVision) Total Operating Expense: $34.24 Mil (TTM As of Mar. 2026)


CV CapsoVision Inc CV
10 GF Score
Price $7.42
! 1 Warning Sign
View Full Analysis

What is CapsoVision Total Operating Expense?

CapsoVision CV +7.58% 10 Total Operating Expense is $34.24 Mil as of Mar. 2026. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

CapsoVision's Total Operating Expense for the three months ended in Mar. 2026 was $8.42 Mil. CapsoVision's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $34.24 Mil.

CapsoVision Total Operating Expense Related Terms

CapsoVision Total Operating Expense Historical Data

* Premium members only.

The historical data trend for CapsoVision's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CapsoVision Total Operating Expense Chart

CapsoVision Annual Data
Trend Dec23 Dec24 Dec25
Total Operating Expense
16.84 26.29 32.69

CapsoVision Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.88 6.46 9.93 9.42 8.42
CV
10GF Score
CapsoVision Inc CV
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CapsoVision Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $34.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $34.24 Mil mean?
CapsoVision (CV) has a Total Operating Expense of $34.24 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on CapsoVision and its competitors.
Is CapsoVision's Total Operating Expense too high?
CapsoVision's current Total Operating Expense is $34.24 Mil. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's Total Operating Expense compare to SENS and MASS?
CapsoVision's Total Operating Expense of $34.24 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on CapsoVision and its competitors. CapsoVision's current Total Operating Expense is $34.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current Total Operating Expense of $34.24 Mil. The current Total Operating Expense is $34.24 Mil. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For CapsoVision (CV), the current Total Operating Expense is $34.24 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CapsoVision Business Description

Other Exchanges H6U:Germany
Address 18805 Cox Avenue, Suite 250, Saratoga, CA, USA, 95070
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score

Get the complete analysis for CV

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.42
Price